RxDoctor Payments Data

Theresa Lipe

Family · Perryville, MONPI 1518315480

Payments from drug & device makers

$4,333in general payments, 2019–2025

Across 215 payments — averaging $20.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Lilly USA, LLC$317
  • Novartis$199
  • Novo Nordisk$180
  • Boehringer Ingelheim$138
  • Amgen$118
  • plus $730 from 19 others

What the payments were for

  • Food & beverage$4,333100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,333 in reported general payments places this provider in the 90th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin27$25,808
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$14,556
FarxigaDapagliflozin Propanediol11$11,834
KerendiaFinerenone17$5,502
Atorvastatin Calcium100$786
Gabapentin38$543
Lisinopril63$481
Levothyroxine Sodium51$358
Albuterol Sulfate HfaAlbuterol Sulfate16$351
Duloxetine Hcl16$321
Potassium Chloride23$297
Amlodipine Besylate69$275
Fluticasone Propionate24$273
Metoprolol Succinate17$222
Metformin Hcl30$218

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$138$25,80827 claims
GSKTrelegy Ellipta$82$14,55616 claims
AstraZenecaFarxiga$41$11,83411 claims
BayerKerendia$20$5,50217 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,812 family providers in Missouri.

Other family in Perryville

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →